Search company, investor...
Search
NuraLogix company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

nuralogix.ai

Founded Year

2015

Stage

Incubator/Accelerator | Alive

Mosaic Score

+120 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About NuraLogix

NuraLogix has developed a technology for detecting hidden emotions called Transdermal Optical Imaging (TOI), which utilizes a conventional video camera to extract facial blood flow information from the human face. By applying advanced machine learning algorithms and neuroscience, the company is able to use this information to model and detect hidden/invisible human emotions regardless of the presence or absence of facial expressions.

NuraLogix Headquarters Location

250 Yonge St, Suite 1801

Toronto, Ontario,

Canada

+1 (416) 368-6000

ESPs containing NuraLogix

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTHMARKET STRENGTHLEADERHIGHFLIEROUTPERFORMERCHALLENGER
Life Sciences / Biopharma Tech

The companies in this market develop ways to measure indicators of vital signs — such as body temperature, pulse, respiratory rate, and blood pressure — that can help guide treatment decisions and lead to improved patient outcomes. These vendors leverage a variety of data collection modalities, from wearables to digital devices.

NuraLogix named as Outperformer among 11 other companies, including Whoop, Oura, and Empatica.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing NuraLogix

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

NuraLogix is included in 7 Expert Collections, including Medical Devices.

M

Medical Devices

8,490 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

C

Conference Exhibitors

5,302 items

T

Telehealth

2,853 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

H

Health Monitoring & Diagnostics

986 items

Companies offering smartphone-based health monitoring & diagnostic solutions (using native components of the smartphone, e.g. camera, microphone, accelerometer, gyroscope, etc.). Companies tagged as #SmartphoneBasedDiagnostics

I

Insurtech

69 items

H

Health IT

8,881 items

NuraLogix Patents

NuraLogix has filed 20 patents.

The 3 most popular patent topics include:

  • Abnormal psychology
  • Cardiovascular physiology
  • Machine learning
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/2/2020

5/24/2022

Blood pressure, Cardiovascular physiology, Linear filters, Medical equipment, Angiology

Grant

Application Date

12/2/2020

Grant Date

5/24/2022

Title

Related Topics

Blood pressure, Cardiovascular physiology, Linear filters, Medical equipment, Angiology

Status

Grant

Latest NuraLogix News

08:15 EDT NuraLogix researchers announce AI models that can predict Metabolic Risks

Aug 10, 2022

News provided by Share this article Share this article TORONTO, Aug. 10, 2022 /CNW/ - Researchers at NuraLogix, a global leader in HealthTech AI, announced today that they have developed AI models that can predict a person's risk of Type 2 Diabetes, Hypercholesterolemia, Hypertriglyceridemia and Hypertension. This is important because it will someday allow people to screen themselves using any device with a video camera such as a smartphone or tablet. NuraLogix researchers announce AI models that can predict Metabolic Risks (CNW Group/NuraLogix Corporation) Researchers at the company trained their machine learning based models on the facial blood flow patterns of tens of thousands of subjects who had been diagnosed with the above conditions. All of the models predicted with a minimum AUC > 0.80. Compare this with the classic Framingham model for predicting cardiovascular disease which had an AUC in the range of 0.70. "This technology is a disruptive tool for population health," said Dr. Keith Thompson, Primary Care Physician of over 30 years, and Chief Medical Officer at NuraLogix, "We live in an Era where 1/2 of the globe is without access to health care, and in both developed and underdeveloped countries, there are shortages of Human Health resources. Traditional medical encounters are time consuming and costly for most people. Tools like this allow us to democratize NCD screening globally to regions in need by moving away from traditional physician face to face encounters and laboratory services, by allowing screening through the ubiquitous technology of smart phones. Given the vast majority of people with metabolic risk factors are unaware they have a condition and may not have access to screening in its current forms, the technology from NuraLogix can literally change the global course of human health history." "Type 2 Diabetes, Hypertriglyceridemia, Hypercholesterolemia, and Hypertension have commonalities which are often associated with metabolic syndrome. However, each of the above conditions have distinct characteristics of their own," said Dr. Naresh Vempala, Director of Research at NuraLogix, "What makes our touchless technology seminal is that our classifier models can extract hidden and unique information about each of these health risks through facial blood flow patterns and predict them with a high degree of accuracy. This is unprecedented in health AI." About NuraLogix NuraLogix are the creators of the world's first contactless blood pressure measurement technology. The company's patented technology can measure 30+ health and wellness parameters using Transdermal Optical Imaging (TOI™), a patented technique developed by the company in which a conventional video camera is used to extract facial blood flow information from the human face. This is demonstrated in the company's groundbreaking app Anura™ and Anura Lite™. Disclaimers: Note: In the United States, this product is for Investigational Use only. The performance characteristics of this product have not been established. SOURCE NuraLogix Corporation

NuraLogix Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

NuraLogix Rank

  • When was NuraLogix founded?

    NuraLogix was founded in 2015.

  • Where is NuraLogix's headquarters?

    NuraLogix's headquarters is located at 250 Yonge St, Suite 1801, Toronto.

  • What is NuraLogix's latest funding round?

    NuraLogix's latest funding round is Incubator/Accelerator.

  • Who are the investors of NuraLogix?

    Investors of NuraLogix include Plug and Play Accelerator.

  • Who are NuraLogix's competitors?

    Competitors of NuraLogix include MX Labs and 7 more.

You May Also Like

Binah.ai Logo
Binah.ai

Binah.ai is the developer of a real-time vital signs measurement app that only requires a smartphone, laptop, or tablet camera. Its app supports iOS devices, Android mobile devices, and Windows laptops and desktops.

Lapetus Solutions Logo
Lapetus Solutions

Lapetus Solutions provides customized predictive life event solutions to life insurers, reinsurers. life settlements, pension funds, and annuities for health care, long-term care, and financial planning.

Sonde Health Logo
Sonde Health

Sonde Health is a digital medicine company that develops a voice-based technology with the potential to monitor and diagnose mental and physical health. Sonde's technology works by sensing and analyzing subtle changes in the voice to create a range of persistent brain, muscle, and respiratory health measurements that provide a more complete picture of health in just seconds.

MyFiziq Logo
MyFiziq

MyFiziq is a revolutionary technology embedded in a partner's app that uses pictures from the smartphone to create a representation in the form of a 3D avatar with circumference measurements. The company leverages the power of computer vision, machine learning, and patented algorithms to process these images on secure, enterprise-level infrastructure, delivering an end-to-end experience.

N
Neuro.net

Neuro.net is a technology and voice AI solutions company. The company provides contact center AI, voice biometrics, and speech analytic solutions for banks, insurance, telecom, retail, e-commerce, transport, and logistics industries. It is based in San Jose, California.

V
Vitacam

Vitacam measures a patient's vital parameters from a live camera feed or video clip.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.